These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 1535086)

  • 1. Internalization of HIV glycoprotein gp120 is associated with down-modulation of membrane CD4 and p56lck together with impairment of T cell activation.
    Cefai D; Ferrer M; Serpente N; Idziorek T; Dautry-Varsat A; Debre P; Bismuth G
    J Immunol; 1992 Jul; 149(1):285-94. PubMed ID: 1535086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 glycoprotein gp120 disrupts CD4-p56lck/CD3-T cell receptor interactions and inhibits CD3 signaling.
    Hubert P; Bismuth G; Körner M; Debré P
    Eur J Immunol; 1995 May; 25(5):1417-25. PubMed ID: 7774645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 down-regulates CD4 costimulation of TCR/CD3-directed tyrosine phosphorylation through CD4/p56lck dissociation.
    Kanner SB; Haffar OK
    J Immunol; 1995 Mar; 154(6):2996-3005. PubMed ID: 7876562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus-1 glycoproteins gp120 and gp160 specifically inhibit the CD3/T cell-antigen receptor phosphoinositide transduction pathway.
    Cefai D; Debre P; Kaczorek M; Idziorek T; Autran B; Bismuth G
    J Clin Invest; 1990 Dec; 86(6):2117-24. PubMed ID: 1979339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus gp120 and derived peptides activate protein tyrosine kinase p56lck in human CD4 T lymphocytes.
    Hivroz C; Mazerolles F; Soula M; Fagard R; Graton S; Meloche S; Sekaly RP; Fischer A
    Eur J Immunol; 1993 Mar; 23(3):600-7. PubMed ID: 7680610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lymphocyte-specific tyrosine protein kinase p56lck is endocytosed in Jurkat cells stimulated via CD2.
    Marie-Cardine A; Maridonneau-Parini I; Ferrer M; Danielian S; Rothhut B; Fagard R; Dautry-Varsat A; Fischer S
    J Immunol; 1992 Jun; 148(12):3879-84. PubMed ID: 1351089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. gp120 ligation of CD4 induces p56lck activation and TCR desensitization independent of TCR tyrosine phosphorylation.
    Goldman F; Jensen WA; Johnson GL; Heasley L; Cambier JC
    J Immunol; 1994 Oct; 153(7):2905-17. PubMed ID: 7522245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of tyrosine kinase p56lck with CD4 inhibits the induction of growth through the alpha beta T-cell receptor.
    Haughn L; Gratton S; Caron L; Sékaly RP; Veillette A; Julius M
    Nature; 1992 Jul; 358(6384):328-31. PubMed ID: 1322497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of CD4 lateral interaction with lymphocyte surface molecules induced by HIV-1 gp120.
    Dianzani U; Bragardo M; Buonfiglio D; Redoglia V; Funaro A; Portoles P; Rojo J; Malavasi F; Pileri A
    Eur J Immunol; 1995 May; 25(5):1306-11. PubMed ID: 7539755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71).
    Chirmule N; McCloskey TW; Hu R; Kalyanaraman VS; Pahwa S
    J Immunol; 1995 Jul; 155(2):917-24. PubMed ID: 7541827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of tyrosine kinase activation blocks the down-regulation of CXC chemokine receptor 4 by HIV-1 gp120 in CD4+ T cells.
    Su SB; Gong W; Grimm M; Utsunomiya I; Sargeant R; Oppenheim JJ; Ming Wang J
    J Immunol; 1999 Jun; 162(12):7128-32. PubMed ID: 10358157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell receptor aggregation, but not dimerization, induces increased cytosolic calcium concentrations and reveals a lack of stable association between CD4 and the T cell receptor.
    Ratcliffe MJ; Coggeshall KM; Newell MK; Julius MH
    J Immunol; 1992 Mar; 148(6):1643-51. PubMed ID: 1531842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequestration of p56(lck) by gp120, a model for TCR desensitization.
    Goldman F; Crabtree J; Hollenback C; Koretzky G
    J Immunol; 1997 Mar; 158(5):2017-24. PubMed ID: 9036944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling via the inositol phospholipid pathway by T cell antigen receptor is limited by receptor number.
    Graber M; Bockenstedt LK; Weiss A
    J Immunol; 1991 May; 146(9):2935-43. PubMed ID: 1826700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No T-cell tyrosine protein kinase signalling or calcium mobilization after CD4 association with HIV-1 or HIV-1 gp120.
    Horak ID; Popovic M; Horak EM; Lucas PJ; Gress RE; June CH; Bolen JB
    Nature; 1990 Dec; 348(6301):557-60. PubMed ID: 1701034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4 ligands inhibit the formation of multifunctional transduction complexes involved in T cell activation.
    Jabado N; Pallier A; Le Deist F; Bernard F; Fischer A; Hivroz C
    J Immunol; 1997 Jan; 158(1):94-103. PubMed ID: 8977179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4 epitope masking by gp120/anti-gp120 antibody complexes. A potential mechanism for CD4+ cell function down-regulation in AIDS patients.
    Amadori A; De Silvestro G; Zamarchi R; Veronese ML; Mazza MR; Schiavo G; Panozzo M; De Rossi A; Ometto L; Mous J
    J Immunol; 1992 May; 148(9):2709-16. PubMed ID: 1374095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comodulation of CD3 and CD4. Evidence for a specific association between CD4 and approximately 5% of the CD3:T cell receptor complexes on helper T lymphocytes.
    Anderson P; Blue ML; Schlossman SF
    J Immunol; 1988 Mar; 140(6):1732-7. PubMed ID: 2964480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of CD4+ T cell activation and adhesion by peptides derived from the gp160.
    Corado J; Mazerolles F; Le Deist F; Barbat C; Kaczorek M; Fischer A
    J Immunol; 1991 Jul; 147(2):475-82. PubMed ID: 1677023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4-independent signal transduction through the T-cell receptor (TCR/CD3).
    Granja CB; Gozashti CS; Dasgupta JD
    Immunology; 1994 Nov; 83(3):414-9. PubMed ID: 7835966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.